Auro Laboratories

Auro Laboratories P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Auro Laboratories (530233.BO) as of Oct 18, 2026 is 80.56. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 29.62 — a change of 171.96% (higher).

P/CF

80.56

YoY

171.96%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Auro Laboratories is 2026 80.56 . P/CF (Price-to-Cash-Flow Ratio) of Auro Laboratories was 2025 29.62 . It decreases by 171.96% higher compared to the previous year.

The Auro Laboratories P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2019
24.78 INR
Jan 1, 2020
18.53 INR
Jan 1, 2021
13.28 INR
Jan 1, 2022
-25.83 INR
Jan 1, 2023
51.89 INR
Jan 1, 2024
9.05 INR
Jan 1, 2025
29.62 INR
Jan 1, 2026
80.56 INR
The Auro Laboratories P/CF history
YEARP/CFYoY
80.56+171.96%
29.62+227.25%
9.05-82.55%
51.89-300.86%
-25.83-294.46%
13.28-28.30%
18.53-25.23%
24.78-11.91%
28.13+7.19%
26.24+21.46%
21.60-109.91%
-218.03-674.01%
37.98—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Auro Laboratories Stock analysis

What does Auro Laboratories do? Auro Laboratories Ltd is a pharmaceutical company headquartered in Mumbai, India. The company engages in the manufacture of active pharmaceutical ingredients (APIs), intermediates, and generic formulations. It operates primarily within the Pharmaceuticals sector. Auro Laboratories offers APIs across various therapeutic categories, including antihistamines, muscle relaxants, diuretics, iron deficiency treatments, anti-diabetics, anti-fungals, anti-ulcer medications, iodine supplements, anti-malarials, analgesics, antacids, and anti-inflammatories. The company also produces intermediates such as Glibenclamide Sulphonamide, Cis-bromo benzoate, Cls-Tosylate, 2-Ethoxy Benzoic Acid, 3,4,5-Trimethoxy Benzoic Acid, and 5-Bromo Phthalide. Additionally, Auro Laboratories provides toll and custom manufacturing services for APIs and intermediates on a contract basis. The company has an international presence, with a significant portion of its production exported to Southeast Asia, the Middle East, and various European countries. Key export destinations include Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. Auro Laboratories went public with its IPO on March 7, 1995. The company's website is http://www.aurolabs.com/. Auro Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Auro Laboratories stock

P/CF (Price-to-Cash-Flow Ratio) of Auro Laboratories is 80.56 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Auro Laboratories changed from 29.62 to 80.56, representing a 171.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Auro Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Auro Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Auro Laboratories

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Auro Laboratories